Camrelizumab Combined With Intraperitoneal Infusion of Nab-paclitaxel, Intravenous Chemotherapy and S-1 in the Treatment of Advanced Gastric Cancer With Peritoneal Metastasis：Single-arm, Prospective Clinical Study

NCT05441254 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Stage IV Gastric Cancer With Metastasis

Interventions

DRUG: Camrelizumab; Nab-paclitaxel; S-1

Sponsor

Zhongshan Hospital Xiamen University

Collaborators

[object Object]